NTLA Latest Headlines

Intellia Therapeutics Earnings Call Highlights Clinical Momentum

at www.tipranks.com (Fri, 21-Aug 8:20 PM)

Biotechs hit a post-pandemic high after mRNA trial win for Moderna, Merck

at seekingalpha.com (Wed, 19-Aug 2:38 PM)

Cathie Wood's Ark adds $30M Cloudflare, $27M Nvidia; cuts $60M Deere

at seekingalpha.com (Mon, 17-Aug 6:15 AM)

Intellia Therapeutics Issues 38,200 RSUs as Inducement Grants to New Hires—What Does This Signal for NTLA’s Growth Ambitions?

Market Chameleon (Mon, 10-Aug 7:55 AM)

Intellia's Positive Phase 3 Data and Strong Cash Position Highlight Road to 2027 Launch

Market Chameleon (Thu, 6-Aug 7:20 AM)

Intellia Therapeutics Sets August 6 Call for Q2 2026 Results and Strategic Business Updates

Market Chameleon (Thu, 30-Jul 8:05 AM)

NTLA Surges as Phase 3 Data Shows 91% Reduction in Severe HAE Attacks—First One-Time Gene Therapy Candidate Nears FDA Submission

Market Chameleon (Mon, 15-Jun 11:48 AM)

Intellia Therapeutics Grants 47,150 RSUs to New Hires—What Does This Signal for Talent Strategy?

Market Chameleon (Mon, 8-Jun 7:53 AM)